Hypersensitivity syndrome induced;Syndrome d'hypersensibilité médicamenteuse au léflunomide

Annales de Dermatologie et de Venereologie

Volumn 130, Issue 5, 2003, Pages 551-552

  Mohty, R ^a   Chaby, G ^a   Pannier, M ^a   Defossez, C ^a   Denoeux, J P ^a   Lok, C ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOMODULATING AGENT; LEFLUNOMIDE;

ADULT; ALOPECIA; ARTICLE; BIOPSY; CASE REPORT; DIARRHEA; DRUG HYPERSENSITIVITY; DRUG RUSH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOM; EROSION; ERYTHEMA; FACE EDEMA; FEMALE; HUMAN; LABORATORY TEST; LYMPHADENOPATHY; MEDICAL EXAMINATION; NAUSEA; RASH; RHEUMATOID ARTHRITIS; SYNDROME; VOMITING;

ARTHRITIS, RHEUMATOID; DRUG ERUPTIONS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISOXAZOLES; MIDDLE AGED;

EID: 0038007268     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Begaud B, Evreux JC, Jouglard J, Lagier G. Imputabilité des effets inattendus ou toxiques des médicaments. Actualisation de la méthode utilisée en France. Therapie. 1985;40:111-8.
2. Barbaud A, Reichert-Penetrat S, Trechot P, Jacquin-Petit MA, Ehlinger A, Noirez V et al. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol 1998;139:49-58.
3. Choquet-Kastylevsky G, Vial T, Santolaria N, Nageotte A, Faure M. Réactions cutanées médicamenteuses: la réalisation de tests cutanés augmente le score d'imputabilité. Ann Dermatol Venereol 2001;128:507-11.
4. Bartlett RR, Anagnostopulos H, Zielinski T, Mattar T, Schleyerbach R. Effects of leflunomide on immune responses and models of inflammation. Springer Semin Immunopathol 1993;14:381-94.
5. Smolen JS, Kalden JR, Scott DL, Rozman B, Kvien TK, Larsen A et al. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group. Lancet 1999;353:259-66.
6. Le Cleach L, Fillet AM, Agut H, Chosidow O. Human herpes virus 6 and 7. New roles yet to be discovered? Arch Dermatol 1998;134:1155-7.
7. Suzuki Y, Inagi R, Aono T, Yamanishi K, Shiohara T. Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol 1998;134:1108-12.